Novo Integrated Sciences, Inc.

NasdaqCM:NVOS Stock Report

Mkt Cap: US$7.4m

Novo Integrated Sciences Past Performance

How has Novo Integrated Sciences performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-50.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NVOS is currently unprofitable.

Growing Profit Margin: NVOS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NVOS is unprofitable, and losses have increased over the past 5 years at a rate of 50.1% per year.

Accelerating Growth: Unable to compare NVOS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NVOS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-4.1%).


Return on Equity

High ROE: NVOS has a negative Return on Equity (-27.84%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies